Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Reset all filters
01 1Sanofi
02 1TAPI Technology & API Services
03 2Curia
04 1Lek Pharmaceuticals
05 1Letco Medical
06 1Medisca
07 2Olon S.p.A
08 2Pcca
09 2Teva Pharmaceutical Industries
Reset all filters
01 1France
02 3Israel
03 2Italy
04 1Slovenia
05 4U.S.A
06 2United Kingdom
Reset all filters
01 4Active
02 2Inactive
03 7Blank
01 2Valid
02 11Blank
Reset all filters
01 13Blank
Reset all filters
01 13Blank
Reset all filters
01 13Blank
Reset all filters
01 117337-0061
02 138779-0303
03 147848-006
04 147848-052
05 151927-0295
06 151927-1706
07 155486-1587
08 155486-1599
09 162991-2858
10 184644-006
11 3Blank
01 13Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3169
Submission : 1978-03-06
Status : Inactive
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-05-31
Pay. Date : 2012-11-07
DMF Number : 14944
Submission : 2000-06-28
Status : Active
Type : II
Certificate Number : CEP 2005-107 - Rev 03
Issue Date : 2025-02-28
Type : Chemical
Substance Number : 551
Status : Valid
NDC Package Code : 84644-006
Start Marketing Date : 2024-11-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30497
Submission : 2016-04-15
Status : Active
Type : II
NDC Package Code : 17337-0061
Start Marketing Date : 2015-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2019-03-06
Pay. Date : 2018-09-28
DMF Number : 33022
Submission : 2018-09-27
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16194
Submission : 2002-10-17
Status : Inactive
Type : II

NDC Package Code : 38779-0303
Start Marketing Date : 2015-08-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

NDC Package Code : 47848-006
Start Marketing Date : 2017-11-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 51927-0295
Start Marketing Date : 2023-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

NDC Package Code : 51927-1706
Start Marketing Date : 2013-06-27
End Marketing Date : 2026-06-30
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

NDC Package Code : 47848-052
Start Marketing Date : 2016-03-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT

44
PharmaCompass offers a list of Dihydroergotamine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydroergotamine Mesylate manufacturer or Dihydroergotamine Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydroergotamine Mesylate manufacturer or Dihydroergotamine Mesylate supplier.
PharmaCompass also assists you with knowing the Dihydroergotamine Mesylate API Price utilized in the formulation of products. Dihydroergotamine Mesylate API Price is not always fixed or binding as the Dihydroergotamine Mesylate Price is obtained through a variety of data sources. The Dihydroergotamine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dihydroergotamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroergotamine Mesylate, including repackagers and relabelers. The FDA regulates Dihydroergotamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroergotamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroergotamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroergotamine Mesylate supplier is an individual or a company that provides Dihydroergotamine Mesylate active pharmaceutical ingredient (API) or Dihydroergotamine Mesylate finished formulations upon request. The Dihydroergotamine Mesylate suppliers may include Dihydroergotamine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroergotamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 9 companies offering Dihydroergotamine Mesylate
Get in contact with the supplier of your choice: